| P50 | author | Darpan I Patel | Q87938046 |
| P2093 | author name string | Nicolas Musi | |
| | Derek Wallace | |
| | Addanki Pratap Kumar | |
| | Paul Rivas | |
| | Amber Gallegos | |
| | Kira Abuchowski | |
| P2860 | cites work | Novel investigational biologics for the treatment of cancer cachexia | Q38202666 |
| | Aerobic exercise training as therapy for cardiac and cancer cachexia. | Q38286946 |
| | Protective effect of Panax ginseng in cisplatin-induced cachexia in rats. | Q39173139 |
| | A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls | Q40428308 |
| | NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes | Q40852716 |
| | Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha | Q41027232 |
| | A Western-type diet accelerates tumor progression in an autochthonous mouse model of prostate cancer | Q41460209 |
| | Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. | Q43200752 |
| | Health behaviors of cancer survivors: examining opportunities for cancer control intervention | Q46825182 |
| | A new horizon of herbal medicines in anorexia-cachexia syndrome | Q47178940 |
| | Anaerobic exercise reduces tumor growth, cancer cachexia and increases macrophage and lymphocyte response in Walker 256 tumor-bearing rats. | Q53461408 |
| | Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and Strength | Q60298077 |
| | Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer | Q62978246 |
| | The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer | Q71637319 |
| | The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer | Q73082097 |
| | Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation | Q82286516 |
| | Effects of prostate cancer and exercise training on left ventricular function and cardiac and skeletal muscle mass | Q90667307 |
| | Association of Muscle Mass with Survival after Radical Prostatectomy in Patients with Prostate Cancer | Q92648759 |
| | Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway | Q24531184 |
| | Butanol fraction containing berberine or related compound from nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells | Q24653581 |
| | Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract | Q24676177 |
| | Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract | Q24680138 |
| | Activation of ATP-ubiquitin-dependent proteolysis in skeletal muscle in vivo and murine myoblasts in vitro by a proteolysis-inducing factor (PIF) | Q28344353 |
| | The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer | Q33874156 |
| | Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. | Q33909028 |
| | Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders. | Q33941892 |
| | Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss | Q33950842 |
| | Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine | Q33958795 |
| | Cachexia in cancer patients | Q33962236 |
| | NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle | Q33985083 |
| | The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. | Q33987349 |
| | Induction of muscle protein degradation and weight loss by a tumor product | Q34062630 |
| | Mechanism of muscle protein degradation induced by a cancer cachectic factor | Q34067595 |
| | Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression | Q34085366 |
| | Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management | Q34108620 |
| | Phellodendron amurense bark extract prevents progression of prostate tumors in transgenic adenocarcinoma of mouse prostate: potential for prostate cancer management. | Q34110197 |
| | The anti-inflammatory effect of exercise | Q34403605 |
| | Cancer cachexia, mechanism and treatment | Q34669440 |
| | Loss of the inducible Hsp70 delays the inflammatory response to skeletal muscle injury and severely impairs muscle regeneration | Q34693368 |
| | Nutritional interventions for cancer-induced cachexia | Q35019743 |
| | Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia | Q35536351 |
| | Mechanisms of disuse muscle atrophy: role of oxidative stress | Q36001985 |
| | JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia | Q36176015 |
| | Extracting the Benefit of Nexrutine® for Cancer Prevention | Q36236997 |
| | Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation | Q36354640 |
| | Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and Obesity | Q36469104 |
| | Oxidative stress, chronic disease, and muscle wasting | Q36723742 |
| | Survival pathways in hypertrophy and heart failure: the gp130-STAT axis | Q36961847 |
| | Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. | Q37671739 |
| P433 | issue | 16 | |
| P304 | page(s) | e14217 | |
| P577 | publication date | 2019-08-01 | |
| P1433 | published in | Physiological Reports | Q15716763 |
| P1476 | title | Nexrutine® preserves muscle mass similar to exercise in prostate cancer mouse model | |
| P478 | volume | 7 | |